Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells

Nature Medicine

Volumn 6, Issue 1, 2000, Pages 56-61

  Klein, Ludger ^a,d   Klugmann, Matthias ^b,e   Nave, Klaus Armin ^b   Tuohy, Vincent K ^c   Kyewski, Bruno ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c LERNER RESEARCH INSTITUTE   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e INF 515   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; EXON; IMMUNOLOGICAL TOLERANCE; MOUSE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE;

ALTERNATIVE SPLICING; ANIMALS; ANIMALS, NEWBORN; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITHELIAL CELLS; EPITOPES; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MULTIPLE SCLEROSIS; MYELIN PROTEOLIPID PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELF TOLERANCE; STROMAL CELLS; T-LYMPHOCYTES; THYMECTOMY; THYMUS GLAND; VARIATION (GENETICS);

ANIMALIA;

EID: 0033984067     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/71540     Document Type: Article

References (46)

1. Kisielow, P. & von Boehmer, H. Development and selection of T cells: facts and puzzles. Adv. Immunol. 58, 87-209 (1995).
2. Stockinger, B. T lymphocyte tolerance: From thymic deletion to peripheral control mechansims. Adv. Immunol. 71, 229-265 (1999).
3. Anderton, S., Burkhart, C., Metzler, B. & Wraith, D. Mechanisms of central and peripheral T-cell tolerance: lessons from experimental models of multiple sclerosis. Immunol. Rev. 169, 123-137 (1999).
4. Alferink, J., Aigner, S., Reibke, R., Hämmerling, G.J. & Arnold, B. Peripheral T-cell tolerance: the contribution of permissive T-cell migration into parenchymal tissues in the neonate. Immunol Rev. 169, 255-261 (1999).
5. Kojima, K., Reindl, M., Lassmann, H. & Wekerle, H. The thymus and self tolerance: Co-existence of encephalitogenic S100β-specific T cells and their nominal autoantigen in the normal adult rat thymus. Int. Immunol. 9, 897-904 (1997).
6. Hanahan, D Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity. Curr. Opin. Immunol. 10, 656-662 (1998).
7. Klein, L., Klein, T., Rüther, U. & Kyewski, B. CD4 T-cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J. Exp. Med. 188, 5-16 (1998).
8. Heath, V.L., Moore, N.C., Parnell, S.M. & Mason, D.W. Intrathymic expression of genes involved in organ specific autoimmune disease. J. Autoimmun. 11, 309-318 (1998).
9. Sospedra, M. et al. Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanisms in tolerance toward peripheral antigens. J. Immunol. 161, 5918-5929 (1998).
10. Steinman, L. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system. Cell 85, 299-302 (1996).
11. Nave, K.A., Lai, C., Bloom, F.E. & Milner, R.J. Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc. Natl. Acad. Sci. USA 84, 5665-5669 (1987).
12. Pribyl, T.M., Campagnoni, C., Kampf, K. & Handley, V.W., and Campangnoni, A.T. The major myelin protein genes are expressed in the human thymus. J. Neurosci. Res. 45, 812-819 (1996).
13. Voskuhl, R.R. Myelin protein expression in lymphoid tissues: Implications for peripheral tolerance. Immunol. Rev. 164, 81-92 (1998).
14. Martin, R., McFarland, H.F. & McFarlin, D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10, 153-187 (1992).
15. Wekerle, H. Experimental autoimmune encephalomyelitis as a model of immune-mediated CNS disease. Curr. Opin. Neurobiol. 3, 779-784 (1993).
16. Tuohy, V.K., Sobel, R.A. & Lees, M.B. Myelin proteolipid protein-induced experimental allergic encephalomyelitis. Variations of disease susceptibility in different strains of mice. J. Immunol. 140, 1868-1873 (1988).
17. Encinas, J.A. et al. Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. J. Immunol. 157, 2186-2192 (1996).
18. Butterfield, R.J. et al. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J. Immunol. 161, 1860-1867 (1998).
19. Encinas, J.A. et al. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing IL2. Nature Genet. 21, 158-160 (1999).
20. Wekerle, H., Bradl, M., Linington, C , Kaab, C. & Kojima, K. The shaping of the brain-specific T lymphocyte repertoire in the thymus. Immunol. Rev. 149, 231-243 (1996).
21. Harrington, C.J. et al. Differential tolerance is induced in T-cells recognizing distinct epitopes of myelin basic protein. Immunity 8, 571-580 (1998).
22. Targoni, O.S. & Lehmann, P.V. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187, 2055-2065 (1998).
23. Klugmann, M. et al. Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18, 59-70 (1997).
24. Oukka, M. et al. CD4 T-cell tolerance to nuclear proteins induced by medullary thymic epithelium. Immunity 4, 545-553 (1996).
25. Smith, K.M., Olson, D.C., Hirose, R. & Hanahan, D. Pancreatic gene expression in rare cells of the thymic medulla: Evidence for functional contribution to T-cell tolerance. Int. Immunol. 9, 1355-1365 (1997).
26. Fritz, R.B. & Zhao, M.-L. Active and passive experimental autoimmune encephalomyelitis in strain 129/J (H-2°) mice. J. Neurosc. Res. 45, 471-474 (1996).
27. Tuohy, V.K., Zu, Z., Sobel, R.A., Laursen, R.A. & Lees, M.B. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL/J mice. J. Immunol. 142, 1523-1527 (1989).
28. Greer, J.M., Kuchroo, V.K., Sobel, R.A. & Lees, M.B. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (178-191) for SJL/J mice. J. Immunol. 149, 783-788 (1992)
29. Greer, J.M. et al. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J. Immunol. 156, 371-379 (1995).
30. Tuohy, V.K. & Thomas, D.M. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T-cell determinant for SJL/J mice. J. Neuroimmunol. 56, 161-170 (1995).
31. Miller, S.D. et al. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol. Rev. 144, 225-244 (1995).
32. McRae, B.L., Vanderlugt, C.L., Dal Canto, M.C. & Miller, S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182, 75-85 (1995).
33. Yu, M., Johnson, J.M. & Tuohy, V.K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: A basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183, 377-383 (1996).
34. Miller, S.D. et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nature Med. 3, 1333-1136 (1997).
35. Vanderlugt, C.L. et al. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol. Rev. 164, 63-72 (1998).
36. Tuohy, V.K. et al. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 164, 93-110 (1998).
37. Segal, B.M. & Shevach, E.M. IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 184, 771-775 (1996).
38. Chang, J.T., Shevach, E.M. & Segal, B.M. Regulation of interleukin (IL)-12 receptor beta2 subunit expression by endogenous IL-12: a critical step in the differentiation of pathogenetic autoreactive T cells. J. Exp. Med. 189, 969-978 (1999).
39. Markovic-Plese, S. et al. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155, 982-992 (1995).
40. Trotter, J. et al. T cell recognition of myelin proteolipid protein and myelin proteolipid peptides in the peripheral blood of multiple sclerosis and control subjects. J. Neuroimmunol 15, 172-178 (1998).
41. Tuohy, V.K., Yu, M., Kawcak, J.A. & Kinkel, R.P. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 189, 1033-1042 (1999).
42. Tuohy, V.K., Yu, M., Weinstock-Guttman, B. & Kinkel, R.P. Diversity and plasticity of self recognition during the development of multiple sclerosis. J. Clin. Invest. 99, 1682-1690 (1997).
43. Egwuagu, C.E., Charukamnoetkanok, P. & Gery, I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J. Immunol. 159, 3109-3112 (1997).
44. Pugliese, A. et al. The Insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nature Genet. 15, 293-297 (1997).
45. Vafiadis, P. et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nature Cenet. 15, 289-292 (1997).
46. Kyewski, B.A., Fathman, C.G. & Rouse, R.V. Intrathymic presentation of circulating non-MHC antigens by medullary dendritic cells. An antigen-dependent microenvironment for T cell differentiation. J. Exp. Med. 163, 231-246 (1986).